What is ankylosing spondylitis (AS), a chronic inflammatory disease affecting the spine in younger adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Ankylosing Spondylitis

Ankylosing spondylitis (AS) is a chronic inflammatory autoimmune disease primarily affecting the axial skeleton, characterized by bilateral sacroiliitis, inflammatory back pain, progressive spinal fusion through entheseal ossification, and a strong genetic association with HLA-B27 (present in 90-95% of patients). 1

Disease Classification and Spectrum

AS represents the most severe and radiographically advanced form within the axial spondyloarthritis (axSpA) spectrum. 2 The broader axSpA category encompasses:

  • Radiographic axial SpA (classic AS): Definite structural changes visible on plain radiographs 2
  • Non-radiographic axial SpA: Inflammatory changes detectable only on MRI without radiographic sacroiliitis 2

AS is distinguished from other spondyloarthropathies by universal sacroiliac joint involvement and higher propensity for complete spinal ankylosis. 2

Epidemiology

  • Prevalence: 0.1-0.5% of the general population, with estimates including early forms ranging from 0.2-1.4% 1, 2
  • Age of onset: Typically before age 45, often presenting in late adolescence or early adulthood 2
  • Genetic predisposition: HLA-B27 positivity in 74-95% of AS patients, though only 1% of HLA-B27 carriers develop the disease 2, 1

Cardinal Clinical Features

Inflammatory Back Pain

The hallmark symptom, present in 70-80% of patients, with distinct characteristics: 2

  • Insidious onset over weeks to months
  • Improves with exercise but not with rest
  • Worsens at night, particularly in the second half
  • Morning stiffness of prolonged duration (>30 minutes) 1
  • Alternating buttock pain from sacroiliitis 2

Pathologic Process

The disease follows a characteristic anatomic progression: 2

  1. Initial involvement: Bilateral sacroiliac joints (distinguishing AS from other spondyloarthropathies which may show unilateral involvement) 2
  2. Spinal progression: Ascending involvement, most commonly affecting thoracic spine and thoracolumbar junction 2
  3. Entheseal inflammation: Enthesitis, synovitis, and osteitis lead to bone erosion, sclerosis, and ultimately ossification 2
  4. End-stage: Complete ankylosis ("bamboo spine") with loss of spinal mobility 1

Extra-Articular Manifestations

Approximately 30-50% of AS patients develop peripheral involvement: 2

  • Peripheral arthritis: Typically asymmetric, lower extremity predominant
  • Enthesitis: Achilles tendon and plantar fascia most common 2
  • Anterior uveitis: Most frequent extra-articular manifestation 3, 4
  • Inflammatory bowel disease: Associated in subset of patients 4
  • Cardiovascular: Aortitis, conduction abnormalities 4
  • Pulmonary: Apical fibrosis in advanced disease 4

Diagnostic Challenges

A critical diagnostic delay of 4.9-7 years persists between symptom onset and diagnosis, highlighting the difficulty in early recognition. 2, 1 This delay occurs because:

  • Inflammatory back pain symptoms are present in 5-15% of the general population, creating diagnostic noise 2
  • Radiographic changes evolve slowly over years, with structural damage lagging behind symptoms by 7+ years 2
  • Early disease may only show inflammatory changes on MRI without radiographic findings 2

Diagnostic Criteria Evolution

Modified New York Criteria (Historical)

Required radiographic sacroiliitis plus clinical criteria, missing patients in early disease stages. 2

ASAS Classification Criteria (Current)

Designed for research purposes, incorporates MRI findings to capture non-radiographic disease, though these criteria are not intended for definitive clinical diagnosis. 2

Disease Impact and Prognosis

Untreated entheseal inflammation progresses inexorably to fibrosis and ossification at affected sites, leading to: 1

  • Functional decline: Progressive loss of spinal mobility and normal posture 2
  • Work disability: Substantial interference with employment and daily activities 1
  • Quality of life: Chronic pain, stiffness, and psychological burden 2, 1
  • Complications: Increased fracture risk from rigid, osteoporotic spine 3

Common Diagnostic Pitfalls

  • Dismissing young adults with chronic back pain as having mechanical causes without screening for inflammatory features 2
  • Waiting for radiographic changes before considering the diagnosis, missing the 7-year window for early intervention 2
  • Failing to recognize that HLA-B27 negativity does not exclude AS (present in 5-26% of AS patients) 2
  • Overlooking extra-articular manifestations (uveitis, IBD) that may precede or accompany axial symptoms 4

References

Guideline

Ankylosing Spondylitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the initial treatment recommendations for a patient with ankylosing spondylitis?
What is the initial workup for a patient suspected of having ankylosing spondylitis?
What part of the sacroiliac joint is involved in ankylosing spondylitis?
What are the characteristic spine features of Ankylosing Spondylitis (AS)?
What is the initial workup for a patient suspected of having ankylosing spondylitis?
What is the best treatment for a patient with recurrent herpes simplex (HSV) lesions on the nose?
What is the best initial antibiotic coverage for an elderly inpatient with aspiration pneumonia and significant medical history, considering potential impaired renal function?
What is the differential diagnosis for a 26-week pregnant woman with a fetal complex cardiac anomaly, including Mesocardia, Persistent Left Superior Vena Cava (PLSVC), Single Umbilical Artery (SUA), pericardial effusion, pulmonary valvular stenosis, post-stenotic dilation, and Fetal Growth Restriction (FGR)?
What are the management options for a patient with chronic pelvic pain syndrome?
What should the NPH (Neutral Protamine Hagedorn) insulin dose and carbohydrate ratio be for a patient with a blood glucose level of hyperglycemia, currently taking 36 units of NPH insulin with a 1:8 carbohydrate ratio, when reducing prednisone from 70mg to 40mg?
What are the management strategies for hyponatremia in patients with varying volumes and underlying conditions, such as Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), heart failure, or liver disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.